-37%

est. 2Y upside i

HealthcareSeries A

Summer Health is a Sequoia-backed company since 2022.

Rank

#3069

Sector

Digital Health

Est. Liquidity

~2Y

Data Quality

Data: Low

Equity upside appears strongly negative over 2 years.

Last updated: July 3, 2026

Bull (15%)+80%

Multiple expands to 6x on an IPO window or category leadership, yielding $52.8M exit. After 20% dilution, net upside ~80%.

Base (45%)-20%

Exit multiple at entry level (3x) gives $26.4M, but 20% dilution cuts value per share, net -20%.

Bear (40%)-100%

Multiple compresses to 1.5x, exit $13.2M below $19.15M preference stack. Common stock recovers zero, net -100%.

Est. time to liquidity~2.0 years

Preference Stack Risk

severe

Funding Intensity

73%

Total funding $19.15M represents 72% of entry valuation, so common stock is highly subordinate.

Dilution Risk

high

With $19.15M total funding and likely burn rate, a new raise within 2 years is probable, diluting common by ~20%.

Secondary Liquidity

none

No secondary market data available.

Questions to Ask at the Interview

Strategic questions based on Summer Health's data — designed to show you've done your homework.

  • 1

    How will Summer Health differentiate from Teladoc and Amazon Clinic in the crowded pediatric telehealth space?

  • 2

    What is the unit economics of the $299/year subscription, and how do they compare to the per-visit model?

  • 3

    What is the expected timeline to liquidity for employees, and have there been any secondary transactions?

Community

Valuation Sentiment

Our model estimates -37% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.